Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KLRD1, Mouse, Clone: 1H1, Abnova™

Mouse monoclonal antibody raised against partial recombinant KLRD1.

Supplier:  Abnova Corporation MAB10543

Catalog No. 89-108-732


Only null left
Add to Cart

Description

Description

Natural killer (NK) cells are a distinct lineage of lymphocytes that mediate cytotoxic activity and secrete cytokines upon immune stimulation. Several genes of the C-type lectin superfamily, including members of the NKG2 family, are expressed by NK cells and may be involved in the regulation of NK cell function. KLRD1 (CD94) is an antigen preferentially expressed on NK cells and is classified as a type II membrane protein because it has an external C terminus. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq

Specifications

Specifications

KLRD1
Monoclonal
Unconjugated
ELISA (1:10000) Western Blot (1:500-1:2000) Flow cytometry (1:200-1:400) The optimal working dilution should be determined by the end user.
KLRD1
KLRD1
Recombinant protein corresponding to human KLRD1.
RUO
3824
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
IgG1
ELISA, Flow Cytometry, Western Blot
1H1
Mouse monoclonal antibody raised against partial recombinant KLRD1.
In ascites (0.03% sodium azide)
CD94
Mouse
100 μL
Primary
Human
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.